Arrowstreet Capital Limited Partnership Makes New Investment in Organigram Holdings Inc. (NASDAQ:OGI)

Arrowstreet Capital Limited Partnership purchased a new position in shares of Organigram Holdings Inc. (NASDAQ:OGI) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 721,330 shares of the company’s stock, valued at approximately $1,153,000. Arrowstreet Capital Limited Partnership owned approximately 0.57% of Organigram as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OGI. Toronto Dominion Bank raised its holdings in Organigram by 803.7% during the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after acquiring an additional 14,876 shares in the last quarter. Clear Harbor Asset Management LLC raised its stake in shares of Organigram by 37.4% during the 4th quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company’s stock worth $72,000 after purchasing an additional 12,250 shares in the last quarter. Finally, Tidal Investments LLC raised its stake in shares of Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock worth $3,526,000 after purchasing an additional 149,171 shares in the last quarter. 34.63% of the stock is currently owned by institutional investors and hedge funds.

Organigram Trading Up 6.2 %

NASDAQ:OGI opened at $1.03 on Friday. The stock has a market capitalization of $130.04 million, a PE ratio of -2.71 and a beta of 1.10. Organigram Holdings Inc. has a 1-year low of $0.85 and a 1-year high of $2.17. The firm has a fifty day simple moving average of $1.15 and a 200 day simple moving average of $1.45.

Organigram (NASDAQ:OGI) last released its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative return on equity of 8.59% and a negative net margin of 31.69%. On average, equities analysts predict that Organigram Holdings Inc. will post -0.19 earnings per share for the current fiscal year.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.